Related Articles
PROGRESS IN RADIOIMMUNOTHERAPY OF HEAD AND NECK-CANCER (REVIEW)
IMMUNE CELLS AND CYTOKINES - THEIR ROLE IN CANCER-IMMUNOTHERAPY (REVIEW)
IL-12 immunotherapy of minimal residual disease in murine models of HPV16-associated tumours: induction of immune responses, cytokine production and kinetics of immune cell subsets
CANCER CYTOGENETICS AND MOLECULAR-GENETICS - CLINICAL IMPLICATIONS (REVIEW)
Depletion of Treg cells inhibits minimal residual disease after surgery of HPV16-associated tumours